Risk of Herpes Zoster in Patients Receiving Anti-TNF-α in the Prospective French RATIO Registry-Reference-Cited by-同舟云学术

Risk of Herpes Zoster in Patients Receiving Anti-TNF-α in the Prospective French RATIO Registry

Published:2012-03 Issue:3 Volume:132 Page:726-729
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Serac Gaelle,Tubach Florence,Mariette Xavier,Salmon-Céron Dominique,Ravaud Philippe,Lioté Frederic,Laharie David,Ziza Jean-Marc,Marguerie Laurent,Bonnet Christine,Falgarone Geraldine,Nicolas Nathalie,Lortholary Olivier,Chosidow Olivier

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference14 articles.

1. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists;Askling;Ann Rheum Dis,2007

2. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies;Dixon;Arthritis Rheum,2007

3. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice;Flynn;Immunity,1995

4. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis);Furst;J Rheumatol,2003

5. Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists;García-Doval;Ann Rheum Dis,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine;Biomolecules;2024-06-22

2. Conventional, biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors and varicella zoster virus;Expert Opinion on Pharmacotherapy;2023-03-28

3. Trends in Hospitalization for Tuberculosis and Other Opportunistic Infections in Australian Patients with Inflammatory Joint Diseases;Rheumatology and Therapy;2023-02-04

4. Anti-tumor Necrosis Factor-Alpha Agents;Infectious Complications in Biologic and Targeted Therapies;2022

5. Cytomegalovirus and Other Herpesviruses;Infectious Complications in Biologic and Targeted Therapies;2022